key: cord-0701410-6aenschj authors: Aly, Menna A. E. G.; Saber, Heba G. title: Long COVID and chronic fatigue syndrome: A survey of elderly female survivors in Egypt date: 2021-09-24 journal: Int J Clin Pract DOI: 10.1111/ijcp.14886 sha: b438f1190343b23d3dab0d6013e6f60f11ebff33 doc_id: 701410 cord_uid: 6aenschj OBJECTIVES: This study aimed to investigate post‐COVID‐19 symptoms amongst elderly females and whether they could be a risk factor for developing chronic fatigue syndrome (CFS) later on. METHODS: This was a retrospective cross‐sectional study, in the form of an online survey. A total of 115 responses were finally included. RESULTS: The mean age was 73.18 ± 6.42. Eighty‐nine reported symptoms in the post‐recovery period; of these 54 had no symptoms of CFS, 60 were possible, and only 1 was probable. Fatigue was reported by 66, musculoskeletal symptoms by 56, and sleep problems by 73. Twenty‐nine patients visited a doctor's office as a result. Post‐recovery symptoms were significantly related to stress, sadness and sleep disturbances. Also, stress, sadness, sleep disturbances, fatigue, cognitive impairment, and recurrent falls were all significantly associated with CFS‐like symptoms. CONCLUSIONS: From our findings, the presence of fatigue, cognitive impairment, stress, sadness, sleep disturbances and recurrent falls in the post‐recovery period were all significantly associated with CFS‐like symptoms. To conclude it would be reasonable to screen for long COVID and consider the potential for developing CFS later on. Whether it can be a risk factor for developing CFS‐like other viral infections will need more larger scale studies to confirm this. elderly Egyptian females recovering from COVID-19 and to explore the relationship with CFS which could be a potential long-lasting complication. We performed a retrospective cross-sectional study, in the form of an online survey targeting females over the age of sixty, conducted from mid-September till mid-October 2020. The questionnaire was distributed online via social media platforms. Research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki, and all participants gave informed consent. Inclusion criteria included being over the age of 60, being female with a history of COVID-19 infection confirmed by PCR, and at least 1 month must have passed since testing negative for COVID-19. Cases unconfirmed by PCR were excluded, as well as those with a history of pre-existing depression, CFS, or fibromyalgia, as well as incomplete responses. Sample size was calculated using PASS program version 15, setting the type-1 error (α) at 0.05 and the confidence interval width at 0.06 (margin of error 7.5%). Results from a previous study 11 showed that the prevalence of chronic idiopathic fatigue among survived COVID cases was 10%. Calculation according to these values produced a minimal sample size of 97 cases. A total of 121 ladies responded but 6 of these were excluded and 115 were finally included. The questionnaire (see Appendix) was available in both Arabic and English and covered the following: Recovery duration, time till complete resolution of symptoms, presence of post-recovery symptoms in general, specific symptoms (neurological, sleep, nasopharyngeal, gastro-intestinal, chest, cardiac, musculo-skeletal and nephrological), whether they had visited a doctor recently as a result. In view of the importance of recognising as soon as possible any likelihood of developing CFS symptoms, we collected the sample early in the pandemic. Our aim was to suggest the possibility or probability of developing CFS in the future. Accordingly, responders were then grouped according to their symptoms as those who had clinical symptoms of CFS but 4 months had not elapsed (possible), those with symptoms and 4 months had passed (probable) and finally those who had none of these. Statistical analyses were performed using SPSS 25.0 program. Mean, standard deviation (±SD) and range were used for parametric numerical data, while Median and Interquartile range (IQR) for non-parametric numerical data. Fisher's exact test was used to examine the relationship between two qualitative variables when the expected count is less than 5 in more than 20% of cells. P-value <.05 was considered statistically significant. A total of 115 complete responses were recorded, all were ladies. The mean age was 73.18 ± 6.42. Regarding marital status; 87 (75.7%) were married, 6 (%5.2) were single/divorced, and 22 (19.1%) were widowed. When asked about education 6 (5.2%) had completed primary education, 45 (39.1%) had middle school, and 64 (55.7%) high school or higher. Eighty-nine (77.4%) reported having symptoms in the post-recovery period; of these 54 (47%) had no symptoms of CFS, 60 (52.2%) were possible, and only 1 was probable. Table 1 shows the frequency of symptoms reported in the post-recovery period. Of note fatigue was reported by 66 (57.4%) responders, The presence of post-recovery symptoms was significantly related to stress (P = .005), sadness (P = .007) and sleep disturbances (P < .001) whether increased, fractured or insomnia. Table 2 shows the relationship between the different kinds of post-recovery symptoms reported and CFS (as classified above). Stress, sadness, sleep disturbances, along with fatigue, cognitive impairment and recurrent falls were all significantly associated with CFS-like symptoms. However, duration till recovery and number of days passed since recovery was not related to CFS-like symptoms with P-values of .304 and .234, respectively. This survey targeted elderly females and aimed to investigate post-COVID-19 symptoms and whether they could be a risk factor for developing CFS later on. Symptoms persisted more than a month in 33% of the responders. This was somewhat higher than the findings of the "UK COVID Symptom study" 2 but closer to a multistate survey conducted in the US which found that 35% had not returned to their usual state of 2-3 weeks after testing negative for COVID-19. 12 What's known • Developing new symptoms or suffering from prolonged symptoms after COVID-19 infection is being recognised (long covid). • Elderly patients, and females especially, are more likely to develop complications from COVID-19. • There are similarities between long covid and chronic fatigue syndrome. • This survey targeted elderly females and aimed to investigate post-COVID-19 symptoms and whether they could be a risk factor for developing CFS later on. • Participants who complained of fatigue, cognitive problems, recurrent falls, stress, sadness and sleep problems were significantly related to CFS possibility or probability. An Italian study reported that 87% of those discharged from hospital had at least one symptom 2 months later. 13 surveyed prolonged COVID symptoms. 14 The nature and closeness of these symptoms to CFS prompted us to study this relationship. Participants who complained of fatigue, cognitive problems, recurrent falls, stress, sadness, and sleep problems were significantly related to CFS possibility or probability. Whether COVID-19 infection can initiate the same response has been discussed by several authors. Rodriguez et al confirmed that COVID-19 can cause a significant inflammatory and auto-immune response, 17 and a Mexican cohort study found that symptoms of CFS overlapped significantly with those of long COVID syndrome. 18 The limitation of this work is the small sample size and it only focuses on one subset of patients. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. The authors have nothing to disclose. Data available on request from the authors. Covid-19: what do we know about "long covid"? Symptom clusters in COVID-19: a potential clinical prediction tool from the COVID Symptom Study app Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med Shadow burden of undiagnosed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on society: retrospective and prospective-in light of COVID-19 Into the looking glass: post-viral syndrome post COVID-19 Fatigue: relevance and implications in the aging population Chronic fatigue syndrome: occupation, medical utilization, and subtypes in a community based sample Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19 Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network -United States Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute covid-19 Patient-led research collaborative: embedding patients in the Long COVID narrative Post-viral fatigue and COVID-19: lessons from past epidemics COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort Did you experience any arterial or venous blockade (stroke, heart attack, sudden blindness Did you need to visit any new doctors for health issues after your recovery? a. Yes (mention why?)